News H2020 EU Biomolmacs

EU Horizon2020 project: BIOMOLMACS

Innovative Training Networks (ITN) Call: H2020-MSCA-ITN-2019   The main aim of the project BIOMOLMACS is to establish a multidisciplinary training network on the emerging topic of molecular machines. In the last decades, great efforts have been spent on the development of synthetic strategies for the creation of molecular machines, and these efforts have been acknowledged…

Read more...
News PTS: primera planta europea polipéptidos

PTS INAUGURA LA PRIMERA PLANTA EN EUROPA PARA FABRICAR POLIPÉPTIDOS

La empresa valenciana PTS acabamos de inaugurar la primera planta en Europa capaz de fabricar kilos de polipéptidos, polímeros avanzados que imitan a la naturaleza y llevan el fármaco allí donde se necesita, con su metodología patentada.   Inmunoterapia, oncología, enfermedades neurodegenerativas, infecciones bacterianas, terapias génicas… ¿Qué tienen en común? Todas pueden ser tratadas con…

Read more...
Press release

Proyecto PTS 2018

Polypeptide Therapeutic Solutions, S.L. ha desarrollado con éxito durante 2018 un proyecto denominado “DESARROLLO Y VALIDACIÓN DE METODOLOGÍAS ANALÍTICAS PARA ANÁLISIS DE HIDROGELES COMO MATRIZ DE MATERIALES POLIPEPTÍDICOS” para el que ha contado con el apoyo de la Agencia Valenciana de la Innovación, a través de su programa de apoyo “Promoción del talento”, en su…

Read more...
Agreements

PharmaIN Corporation and Polypeptide Therapeutic Solutions announces a collaboration agreement for contract manufacturing

Bothell, WA & Valencia, Spain – 21st September 2018 PharmaIN Corporation and Polypeptide Therapeutic Solutions (PTS) announced today that they have entered into a collaboration agreement for contract manufacturing. Under the agreement, Polypeptide Therapeutic Solutions will provide PharmaIN contract research services and own technology to add as a part of PharmaIN´s Protected Graft Co-Polymer (PGCTM)…

Read more...
Agreements

Polypeptide Therapeutic Solutions and PMC Isochem sign business and technology collaboration agreement in the field of Cosmetic and Therapeutic Polypeptide

Polypeptide Therapeutic Solutions and PMC Isochem sign business and technology collaboration agreement in the field of Cosmetic and Therapeutic Polypeptide. Under the agreement, Polypeptide Therapeutic Solutions will use proprietary technology and research capabilities to offer contract research services from the polypeptide design up to delivery of small quantity of polymer and PMC Isochem will use…

Read more...
Awards

PTS achieves GLP Certification

In December 2017 our quality control department obtained the Good Laboratory Practices (GLP) certification by the Spanish regional health authority. This allows us to carry out physicochemical studies for pharmaceutical and cosmetic products in preclinical phases. This certificate has been obtained due to our high and rigorous quality standards and is internationally recognized in all…

Read more...